Concepedia

Author

Yusuke Onozawa

Shizuoka Cancer CenterORCID

Also Known As

Masahiro Nozawa, Onozawa Yusuke, Onozawa, Yusuke, Y Onozawa, Y. Onozawa, YUSUKE ONOZAWA, Yusuke ONOZAWA, Yusuke Onozawa

203

Publications

2.8K

Citations

28

H-Index

42

Concepts

All Affiliations

Shizuoka Cancer CenterNational Cancer Center Hospital EastAichi Cancer CenterSt. Marianna University School of MedicineKindai University
YO

About

Yusuke Onozawa is an author at Shizuoka Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

31

1.1K

2

Gastroenterology

9

9

394

3

Health Sciences

6

6

184

4

Head And Neck Surgery

2

2

33

5

Public Health

1

1

47

Yusuke Onozawa

×

63

Publications

2.4K

Citations

27

H-Index

YearCitations

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site

Hidetoshi Hayashi, Takayasu Kurata, Yuichi Takiguchi,

Journal of Clinical Oncology

2019

166

Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer

Shuichi Hironaka, Sadamoto Zenda, Narikazu Boku,

Gastric Cancer

2006

145

Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site

Hidetoshi Hayashi, Yuichi Takiguchi, Hironobu Minami,

JAMA Oncology

2020

114

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours

Toshihiko Doi, Atsushi Ohtsu, Takayuki Yoshino,

British Journal of Cancer

2012

96

Phase 2 study of nilotinib as third‐line therapy for patients with gastrointestinal stromal tumor

Akira Sawaki, Toshirou Nishida, Toshihiko Doi,

Cancer

2011

85

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison

Toshiki Masuishi, Hiroya Taniguchi, Satoshi Hamauchi,

Clinical Colorectal Cancer

2016

74

Platinum-based Chemotherapy Plus Cetuximab for the First-line Treatment of Japanese Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of a Phase II Trial

Takayuki Yoshino, Yasuhisa Hasegawa, Shunji Takahashi,

Japanese Journal of Clinical Oncology

2013

73

Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary

Hideki Takeuchi, Toshiaki Saeki, Keisuke Aiba,

International Journal of Clinical Oncology

2015

70

Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Susumu Okano, Takashi Yoshino, M Fujii,

Japanese Journal of Clinical Oncology

2013

67

Phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck (JCOG1008).

Naomi Kiyota, Makoto Tahara, Hirofumi Fujii,

Journal of Clinical Oncology

2020

64

Page 1